FORBES-TATE

Lobbying for IONIS PHARMACEUTICAL, INC. · Biopharmaceutical company developing RNA therapies.

Filing 1st Quarter - Report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 14, 2025

Income

$30,000.00

What the client paid this registrant for the period.

Client based in

California

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 2

Lobbying activity 2

Health Issues

Issues related to Creating Hope Act and issues related to H.R. 5547/S. 476 - Maintaining Investments in New Innovation.

Medicare/Medicaid

Issues related to Creating Hope Act & issues related to H.R. 5547/S. 476 - Maintaining Investment in New Innovation.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.